Home LiteratureArticle Details
PMID: 42339269 Published · epublish English

Single-Stage Double-Level Ilizarov Reconstruction for Distal Congenital Femoral Deficiency in Early Childhood: A Case Report.

Aldzhamal N, Kamal AH, Nashat K

Abstract

Congenital femoral deficiency (CFD) with primary distal involvement (Paley Type 4) is the rarest phenotype in a spectrum that affects roughly 1 in 40,000-100,000 live births. Such children present early with pronounced limb length discrepancy (LLD), genu valgum, and patellofemoral maltracking. We describe a 4-year-old girl who exhibited an 8 cm right-sided LLD, severe distal femoral valgus, and hypoplasia of the lateral femoral condyle. A four-ring Ilizarov frame was applied, and two corticotomies were performed in a single sitting: (1) an oblique distal osteotomy to open-wedge correct valgus while permitting 1 mm day distraction and (2) a midshaft transverse osteotomy lengthened at 1 mm day. After 5 months, 12 cm of regenerated bone restored mechanical alignment and equalized limb length. The patient achieved full, painless knee and hip motion and resumed unrestricted play 7 months after frame removal. No deep infection, neurovascular injury, knee contracture, or regenerate fracture occurred. The case illustrates that carefully planned, simultaneous deformity correction and lengthening can safely deliver length gains beyond those typically reported in single-level procedures while obviating multiple staged surgeries.

Keywords
Ilizarov technique congenital femoral deficiency limb lengthening
Article Info
Journal
Case reports in orthopedics
Abbr.
Case Rep Orthop
ISSN
2090-6749
Language
English
Country/Region
United States
NLM ID
101591806
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]